Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 2 SARA and INAS scores for each patient at baseline and follow-up

From: A longitudinal investigation into cognition and disease progression in spinocerebellar ataxia types 1, 2, 3, 6, and 7

  SARA INAS
Patient Baseline Follow-up Change Baseline Follow-up Change
SCA1 10 15.5 +5.5 5 6 +1
SCA1 10.5 24 +13.5 3 5 +2
SCA2 10 14.5 +4.5 5 5 0
SCA2 9 14.5 +5.5 2 3 +1
SCA3 23.5 28 +4.5 3 6 +3
SCA3 17.0 2153 +7.5 3 9 +6
SCA6 14.5 20.5 +6 1 1 0
SCA6 11.5 16 +4.5 1 1 +2
SCA6 10.5 13 +2.5 0 2 +2
SCA6 16 20 +4 0 1 +1
SCA7 18 26 +8 3 5 +2
SCA7 13 17.5 +4.5 3 5 +2
SCA7 9.5 15 +5.5 2 3 +1